• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    Beltway Confidential

    The major immigration battle brewing in the House

    Susan Ferrechio -
    May 17, 2018 4:00 am
    0
    Secretary of Health and Human Services Alex Azar looks on as President Donald Trump speaks during an event about prescription drug prices in the Rose Garden of the White House, Friday, May 11, 2018, in Washington.
    Healthcare

    Cancer groups approach drug price overhaul with caution

    Robert King -
    May 16, 2018 10:48 pm
    0
    Capt. Paul Kamphaus of the Clermont County Sheriff's Office handles a box of naloxone during a 2017 interview in Batavia, Ohio.
    Healthcare

    Why we support increasing access to naloxone

    Marcelo Bigal -
    May 16, 2018 9:28 pm
    0
    Vermont law allows patients to buy cheaper drugs from Canada
    Healthcare

    Vermont law allows patients to buy cheaper drugs from Canada

    Kimberly Leonard -
    May 16, 2018 5:22 pm
    0
    Attorney Michael Cohen walks down the sidewalk in New York on Wednesday. Federal agents who raided the office of President Trump's personal attorney, were looking for information about payments to a former Playboy playmate and a porn actress who claim to have had affairs with Trump, two people familiar with the investigation said.
    Healthcare

    Top lawyer for Novartis retires following contract with Michael Cohen

    Melissa Quinn -
    May 16, 2018 4:42 pm
    0
    House Minority Leader Nancy Pelosi, D-Calif., and Senate Minority Leader Chuck Schumer, D-N.Y., confer at the Capitol on May 10, 2018.
    Healthcare

    Trump tries to break America’s addiction to high drug prices

    Washington Examiner -
    May 16, 2018 4:29 pm
    0
    Alex Azar is a former health official at HHS, where he served as deputy secretary under former President George W. Bush. He also is a former top executive for pharmaceutical giant Eli Lilly. (Graeme Jennings/Washington Examiner)
    Healthcare

    Alex Azar calls Democratic reforms to lower drug prices ‘gimmicks’ and ineffective

    Robert King -
    May 16, 2018 2:16 pm
    0
    President Donald Trump speaks during an event about prescription drug prices with Health and Human Services Secretary Alex Azar in the Rose Garden of the White House in Washington, Friday, May 11, 2018.
    Beltway Confidential

    Trump tackles soaring prescription drug prices

    Hadley Heath Manning -
    May 15, 2018 9:45 pm
    0
    FILE - In this Wednesday, April 5, 2017, file photo, Dr. Scott Gottlieb speaks during his confirmation hearing before a Senate committee, in Washington, as President Donald Trump's nominee to head the Food and Drug Administration. The FDA has issued new warnings about the danger of patients on medication for opioid addiction taking popular drugs such as Ambien and Xanax that also depress breathing and brain activity. "Careful management of the patient and coordination of care is recommended," rather than denying use of methadone or buprenorphine, FDA Commissioner Gottlieb wrote in a statement issued with the warning.
    Healthcare

    FDA to call out brand name drug companies that block generics

    Robert King -
    May 15, 2018 3:14 pm
    0
    Health worker wearing protective clothing and equipment. Ebola cases have been confirmed in 10 African countries, including Congo where the disease was first reported in 1976.
    Healthcare

    Experimental Ebola vaccine heads to Congo as death toll reaches 19

    Kimberly Leonard -
    May 14, 2018 6:27 pm
    0
    1...878889...159Page 88 of 159
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.